Myriad Genetics Inc. (MYGN) at a glance

Myriad Genetics Inc. (MYGN) is a small-cap Healthcare company. It trades at $3.17, with a -41.3% profit margin and revenue decline of 20.8%. It does not pay a dividend. Vestovix scores it 35/100 overall. Its strongest dimension is Value (48/100) and its weakest is Momentum (18/100). It carries above-market volatility, so expect larger swings.

Price

$3.17

Market cap

$409.0M

P/E ratio

n/a

Dividend yield

None

Beta

1.64

52-week range

$2.74 to $8.59